Higher Stroke Risk Associated With Estrogen Contraceptives in Women With Migraine
Taking estrogen-containing contraceptives increases risk for stroke in women with migraine with aura.
For patients with episodic migraine, fremanezumab is associated with a reduction in the mean number of monthly migraine days.
The episodic cluster headache trial included a total of 106 patients with an average of 17.5 cluster headache attacks per week at baseline.
Compared to placebo, selective serotonin reuptake inhibitors (SSRIs) were associated with a significantly higher risk of headache (risk ratio [RR] 1.06, 95% CI: 1.00 to 1.13; P =.045).